Targeting the distal small intestine, specifically the terminal ileum, remains one of the greatest challenges in oral drug delivery.
Innovation in oral formulation technologies has opened new avenues for the lifecycle management and patent protection of biologics. Technologies such as SNAC, LBFs,…
The success and adoption of oral GLP-1 RAs mark a shift in biologic drug delivery. Technologies such as permeation enhancers, LBFs, and enteric protection have made…
Healthcare systems are facing increasing pressure as record demand, an aging population, the burden of chronic disease, and economic inflation challenge clinics,…
Meeting consumers’ needs is the first priority for any successful business. For over-the-counter (OTC) medications and supplements, oral dosage forms have long been…
Discover how next-generation capsule technologies, including Capsugel(R) Enprotect(R) capsules, are advancing targeted oral drug delivery, improving bioavailability,…
The capsule market is shifting due to the growing importance of ethics and sustainability in driving consumer behavior. The ethical spending market has shown…
Maximizing Productivity in Vegan and Vegetarian Capsules Filling
Sustainability is at the core of our business strategy and operating philosophy.
At first glance, one may consider the selection of the empty hard capsule the simplest and final decision to be made when rolling out a new drug product or food…
Discover how Adare Pharma Solutions, a global technology-driven CDMO, partnered with Lonza Capsugel, the industry leader in specialty capsule technologies, to…
Contact Us